Development and application of AI enabled automated drug delivery system for TACE guided by DSA

Tianming Du; Yin Xiong; Yalian Yu; Yi Wang; Yukang Li; Yan Huang; Xin Xiang; Bin Fu; Chen Li; Hongbo Wang; Meng Niu

doi:10.59717/j.xinn-oncol.2026.100009

The Innovation Oncology > 2026 Vol. 1 > No. 1 > 100009

Next Article Previous Article

ARTICLE Open Access

Cite PDF

Development and application of AI enabled automated drug delivery system for TACE guided by DSA

1.
College of Medicine and Biological Information Engineering, Northeastern University, Shenyang 110819, China
2.
Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China
3.
Department of Otorhinolaryngology, The First Affiliated Hospital of China Medical University, Shenyang 110801, China
4.
Neusoft Medical Systems Co., Ltd, Shenyang 110179, China
5.
These authors contributed equally

More Information

Corresponding authors: lichen@bmie.neu.edu.cn (C.L.); sj_wanghb@163.com (H.W.); niumeng@cmu.edu.cn (M.N.)
Received Date: April 21, 2026

Accepted Date: April 22, 2026

Published Online: April 25, 2026

The Innovation Oncology 1(1), https://doi.org/10.59717/j.xinn-oncol.2026.100009 | Cite this article

GRAPHICAL ABSTRACT

GRAPHICAL ABSTRACT

DownLoad: Full size image

PUBLIC SUMMARY

PUBLIC SUMMARY
1. We developed an intelligent drug delivery system to enhance safety and precision in liver cancer therapy.
  
  It enables automated drug delivery control through real-time imaging monitoring.
  
  The system detects blood flow changes and adjusts dosing to reduce drug reflux.
  
  Results show more stable injection, faster response, and strong adaptability.
  
  It may reduce radiation exposure and improve clinical treatment outcomes.

ABSTRACT

ABSTRACT

Transarterial chemoembolization (TACE) is an important treatment modality for unresectable hepatocellular carcinoma. Real-time monitoring of drug injection and reflux during the procedure is a critical factor influencing both therapeutic efficacy and radiation dose exposure for interventional radiologists. However, existing automatic injection devices lack high-dimensional, real-time closed-loop feedback. To overcome these limitations, we developed AI-FlowTACE, an intelligent drug delivery system that integrates real-time monitoring, adaptive dynamic flow regulation, and precision braking control. AI-FlowTACE can be seamlessly incorporated into clinical workflows to acquire intraoperative DSA images in real time. By analyzing imaging feedback through an embedded Artificial Intelligence (AI) module, the system autonomously guides the injector to achieve adaptive drug delivery. The model architecture achieved segmentation AUCs of 98.15% and 97.23% in two external validation cohorts. In an in vitro simulated vascular model, AI-FlowTACE demonstrated markedly more stable injection performance than manual administration, with the cumulative error consistently maintained within 0.02 mL. In three highly sensitive rabbit blood-flow models, the system achieved drug-adjustment response times of 0.83 s, 0.70 s, and 0.82 s, respectively. In in vivo experiments using a porcine model with human-like vascular anatomy, the response time was 0.8 s, indicating excellent adaptability and feasibility. Furthermore, in real TACE procedures, simulated comparisons with manual injection further validated the system’s adaptive reflux-adjustment capability, while demonstrating a 20% reduction in additional radiation exposure.
- DSA /
- TACE /
- automated drug delivery /
- Intelligent infusion pump

FullText(HTML)

REFERENCES

[1]	Heimbach J.K., Kulik L.M., Finn R.S., et al. (2018). AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358−380. DOI:10.1002/hep.29086 View in Article CrossRef Google Scholar
[2]	Bruix J., Reig M. and Sherman M. (2016). Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterol 150:835−853. DOI:10.1053/j.gastro.2015.12.041 View in Article CrossRef Google Scholar
[3]	Benson A.B., D’Angelica M.I., Abbott D.E., et al. (2021). Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 19:541–565. DOI:10.6004/jnccn.2021.0022 View in Article Google Scholar
[4]	Zhang Y.J., Chen J., Zhou Z., et al. (2025). Transarterial chemoembolization with radiofrequency ablation versus surgical resection for small late-recurrence hepatocellular carcinoma. Radiology 314:e241096. DOI:10.1148/radiol.241096 View in Article CrossRef Google Scholar
[5]	Lu J., Zhao M., Arai Y., et al. (2021). Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: Consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO). Hepatobiliary Surg. Nutr. 10:661−671. DOI:10.21037/hbsn-21-260 View in Article CrossRef Google Scholar
[6]	Li H.B., Huang L., Ni J.Y., et al. (2024). Traditional Chinese medicine in the treatment of adverse reactions after TACE for primary hepatic carcinoma: Effect, mechanism, and potential advantages. Phytomed. 135:156244. DOI:10.1016/j.phymed.2024.156244 View in Article CrossRef Google Scholar
[7]	Duan X., Li H., Chen P., et al. (2024). Transcatheter arterial chemoembolization using CalliSpheres beads loaded with arsenic trioxide for unresectable large or huge hepatocellular carcinoma: A prospective study. Eur. Radiol. 34:1258−1267. DOI:10.1007/s00330-023-10097-1 View in Article CrossRef Google Scholar
[8]	Raoul J.L., Forner A., Bolondi L., et al. (2019). Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treat. Rev. 72:28−36. DOI:10.1016/j.ctrv.2018.11.002 View in Article CrossRef Google Scholar
[9]	Wang C., Zhang L., Yang Z., et al. (2024). Self-fueling ferroptosis-inducing microreactors based on pH-responsive Lipiodol pickering emulsions enable transarterial ferro-embolization therapy. Natl. Sci. Rev. 11:nwad257. DOI:10.1093/nsr/nwad257 View in Article CrossRef Google Scholar
[10]	Llovet J.M., De Baere T., Kulik L., et al. (2021). Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18:293−313. DOI:10.1038/s41575-020-00395-0 View in Article CrossRef Google Scholar
[11]	Lencioni R., de Baere T., Soulen M.C., et al. (2016). Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data. Hepatol. 64:106−16. DOI:10.1002/hep.28453 View in Article CrossRef Google Scholar
[12]	Lee E.W. and Khan S. (2017). Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma. Clin. Mol. Hepatol. 23:265−72. DOI:10.3350/cmh.2017.0111 View in Article CrossRef Google Scholar
[13]	Angileri S.A., Lanza C., Carriero S., et al. (2023). Performance and safety of a reflux-control microcatheter used to perform DEB-TACE with LUMITM beads in HCC patients: Preliminary experience. J. Clin. Med. 12:6630. DOI:10.3390/jcm12206630 View in Article CrossRef Google Scholar
[14]	Stampfl U., Bermejo J.L., Sommer C.M., et al. (2014). Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: A histopathologic study. J. Vasc. Interv. Radiol. 25:1018−1026.e4. DOI:10.1016/j.jvir.2014.03.007 View in Article CrossRef Google Scholar
[15]	Salem R., Johnson G.E., Kim E., et al. (2021). Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: The LEGACY study. Hepatol. 74:2342−52. DOI:10.1002/hep.31819 View in Article CrossRef Google Scholar
[16]	Salem R., Gordon A.C., Mouli S., et al. (2016). Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterol. 151:1155−1163.e2. DOI:10.1053/j.gastro.2016.08.029 View in Article CrossRef Google Scholar
[17]	Salem R., Padia S.A., Lam M., et al. (2019). Clinical and dosimetric considerations for Y90: Recommendations from an international multidisciplinary working group. Eur. J. Nucl. Med. Mol. Imaging. 46:1695−704. DOI:10.1007/s00259-019-04340-5 View in Article CrossRef Google Scholar
[18]	Gabr A., Riaz A., Johnson G.E., et al. (2021). Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: Confirmatory multicenter analysis in 45 explants. Eur. J. Nucl. Med. Mol. Imaging. 48:580−3. DOI:10.1007/s00259-020-04976-8 View in Article CrossRef Google Scholar
[19]	Iacovacci V., Tamadon I., Kauffmann E.F., et al. (2021). A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules. Sci. Robot. 6:eabh3328. DOI:10.1126/scirobotics.abh3328 View in Article CrossRef Google Scholar
[20]	Ahmad S., Beneyto A., Zhu T., et al. (2024). An automatic deep reinforcement learning bolus calculator for automated insulin delivery systems. Sci. Rep. 14:15245. DOI:10.1038/s41598-024-62912-4 View in Article CrossRef Google Scholar
[21]	Gholap A.D., Uddin M.J., Faiyazuddin M., et al. (2024). Advances in artificial intelligence for drug delivery and development: A comprehensive review. Comput. Biol. Med. 178:108702. DOI:10.1016/j.compbiomed.2024.108702 View in Article CrossRef Google Scholar
[22]	Schneider P.J., Pedersen C.A. and Scheckelhoff D.J. (2018). ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2017. Am. J. Health Syst. Pharm. 75:1203−26. DOI:10.2146/ajhp180151 View in Article CrossRef Google Scholar
[23]	Patra D., Sengupta S., Duan W., et al. (2013). Intelligent, self-powered, drug delivery systems. Nanoscale 5(4):1273−83. DOI:10.1039/c2nr32600k View in Article CrossRef Google Scholar
[24]	Bi D., Qu F., Xiao W., et al. (2023). Reactive oxygen species-responsive gel-based microneedle patches for prolonged and intelligent psoriasis management. ACS Nano 17:4346−4357. DOI:10.1021/acsnano.2c08979 View in Article CrossRef Google Scholar
[25]	Litman R.S., O’Neill S. and Beard J.W. (2020). What can we learn from smart-pump infusion data analysis. Br. J. Anaesth. 125:430−432. DOI:10.1016/j.bja.2020.07.002 View in Article CrossRef Google Scholar
[26]	Cao J., Yip H.C., Chen Y., et al. (2023). Intelligent surgical workflow recognition for endoscopic submucosal dissection with real-time animal study. Nat. Commun. 14:6676. DOI:10.1038/s41467-023-42451-8 View in Article CrossRef Google Scholar
[27]	Garrow C.R., Kowalewski K.F., Li L., et al. (2021). Machine learning for surgical phase recognition: A systematic review. Ann. Surg. 273:684−693. DOI:10.1097/SLA.0000000000004425 View in Article CrossRef Google Scholar
[28]	Liu C., Liu Y., Xie R., et al. (2024). The evolution of robotics: Research and application progress of dental implant robotic systems. Int. J. Oral Sci. 16:28. DOI:10.1038/s41368-024-00296-x View in Article CrossRef Google Scholar
[29]	Enayati N., De Momi E. and Ferrigno G. (2016). Haptics in robot-assisted surgery: Challenges and benefits. IEEE Rev. Biomed. Eng. 9:49−65. DOI:10.1109/RBME.2016.2538080 View in Article CrossRef Google Scholar
[30]	Zuo S. and Yang G.Z. (2017). Endomicroscopy for computer and robot assisted intervention. IEEE Rev. Biomed. Eng. 10:12−25. DOI:10.1109/RBME.2017.2686483 View in Article CrossRef Google Scholar
[31]	Mahapatra S., Kumari R. and Chandra P. (2024). Printed circuit boards: System automation and alternative matrix for biosensing. Trends Biotechnol. 42:591−611. DOI:10.1016/j.tibtech.2023.11.002 View in Article CrossRef Google Scholar
[32]	Ahn C.H., Kim T., Jo K., et al. (2025). Two-stage deep learning model for adrenal nodule detection on CT images: A retrospective study. Radiology 314:e231650. DOI:10.1148/radiol.231650 View in Article CrossRef Google Scholar
[33]	Vaswani A., Ramachandran P., Srinivas A., et al. (2021). Scaling local self-attention for parameter efficient visual backbones. 2021 IEEE/CVF conference on computer vision and pattern recognition (CVPR). 12889–12899. DOI:10.1109/CVPR46437.2021.01270. View in Article Google Scholar
[34]	Zhang C., Lei S., Ma A., et al. (2024). Evaluation of tumor microvasculature with 3D ultrasound localization microscopy based on 2D matrix array. Eur. Radiol. 34:5250−5259. DOI:10.1007/s00330-023-10039-x View in Article CrossRef Google Scholar
[35]	Sorop O., van de Wouw J., Chandler S., et al. (2020). Experimental animal models of coronary microvascular dysfunction. Cardiovasc. Res. 116:756−770. DOI:10.1093/cvr/cvaa002 View in Article CrossRef Google Scholar
[36]	Rizk A.A., Dybala M.P., Rodriguez K.C., et al. (2023). Pancreatic regional blood flow links the endocrine and exocrine diseases. J. Clin. Invest. 133:e166185. DOI:10.1172/JCI166185 View in Article CrossRef Google Scholar
[37]	Yarmohammadi H., Gonzalez-Aguirre A.J., Maybody M., Ziv E., et al. (2018). Evaluation of the effect of operator experience on outcome of hepatic artery embolization of hepatocellular carcinoma in a tertiary cancer center. Acad. Radiol. 25:856−860. DOI:10.1016/j.acra.2017.12.011 View in Article CrossRef Google Scholar
[38]	Cho Y., Choi J.W., Kwon H., et al. (2023). Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean liver cancer association. Korean J. Radiol. 24:606−625. DOI:10.3348/kjr.2023.0385 View in Article CrossRef Google Scholar
[39]	van den Hoven A.F., Lam M.G.E.H., Jernigan S., et al. (2015). Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics. J. Exp. Clin. Cancer Res. 34:74. DOI:10.1186/s13046-015-0188-8 View in Article CrossRef Google Scholar
[40]	Basile A., Carrafiello G., Ierardi A.M., et al. (2012). Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc. Intervent. Radiol. 35:765−774. DOI:10.1007/s00270-012-0423-z View in Article CrossRef Google Scholar
[41]	Bargellini I., Lorenzoni V., Lorenzoni G., et al. (2021). Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: A propensity score matching analysis. Eur. Radiol. 31:7512−7522. DOI:10.1007/s00330-021-07905-x View in Article CrossRef Google Scholar
[42]	Shi Q., Zhang X., Wu M., et al. (2023). Emulsifying Lipiodol with pH-sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis. Mater. Today Bio. 23:100873. DOI:10.1016/j.mtbio.2023.100873 View in Article CrossRef Google Scholar
[43]	Scartozzi M., Baroni G.S., Faloppi L., et al. (2010). Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: Efficacy and safety results from a large mono-institutional analysis. J. Exp. Clin. Cancer Res. 29:164. DOI:10.1186/1756-9966-29-164 View in Article CrossRef Google Scholar
[44]	Tsurusaki M. and Murakami T. (2015). Surgical and locoregional therapy of HCC: TACE. Liver Cancer 4:165−175. DOI:10.1159/000367739 View in Article CrossRef Google Scholar
[45]	Chaikof E.L., Dalman R.L., Eskandari M.K., et al. (2018). The society for vascular surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J. Vasc. Surg. 67:2−77.e2. DOI:10.1016/j.jvs.2017.10.044 View in Article CrossRef Google Scholar
[46]	Mondal S.B., Gao S., Zhu N., et al. (2014). Real-time fluorescence image-guided oncologic surgery. Adv. Cancer Res. 124:171−211. DOI:10.1016/B978-0-12-411638-2.00005-7 View in Article CrossRef Google Scholar
[47]	Liu Y.Z., Shah S.K., Sanders C.M., et al. (2023). Utility and usability of laser speckle contrast imaging (LSCI) for displaying real-time tissue perfusion/blood flow in robot-assisted surgery (RAS): Comparison to indocyanine green (ICG) and use in laparoscopic surgery. Surg. Endosc. 37:4803−4811. DOI:10.1007/s00464-022-09590-3 View in Article CrossRef Google Scholar
[48]	Ni Z.L., Bian G.B., Li Z., et al. (2022). Space squeeze reasoning and low-rank bilinear feature fusion for surgical image segmentation. IEEE J. Biomed. Health Inform. 26:3209−3217. DOI:10.1109/JBHI.2022.3154925 View in Article CrossRef Google Scholar
[49]	Jeon S.I., Park H.J., Cho H., et al. (2024). Iodinated cyanoacrylate-based novel liquid embolic compositions with inherent radiopacity for endovascular embolization. Adv. Healthc. Mater. 13:e2401099. DOI:10.1002/adhm.202401099 View in Article CrossRef Google Scholar
[50]	Peart J.M., Sim R.G. and Hofman P.L. (2021). Therapeutic effects of hysterosalpingography contrast media in infertile women: What do we know about the H2O in the H2Oil trial and why does it matter. Hum. Reprod. 36:529−535. DOI:10.1093/humrep/deaa325 View in Article CrossRef Google Scholar
[51]	Vollherbst D.F., Chapot R., Bendszus M., et al. (2022). Glue, onyx, squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin. Neuroradiol. 32:25−38. DOI:10.1007/s00062-021-01066-6 View in Article CrossRef Google Scholar
[52]	Tehrani B.N., Truesdell A.G., Psotka M.A., et al. (2020). A standardized and comprehensive approach to the management of cardiogenic shock. JACC Heart Fail. 8:879−891. DOI:10.1016/j.jchf.2020.09.005 View in Article CrossRef Google Scholar
[53]	Georgopoulos D., Taran S., Bolaki M.,et al. (2025). Mechanical ventilation in patients with acute brain injuries: A pathophysiology-based approach. Am. J. Respir. Crit. Care Med. 211:932−945. DOI:10.1164/rccm.202409-1813SO View in Article CrossRef Google Scholar
[54]	Baker J.R., Beach P.A., Ranada S.I., et al. (2025). Cerebral blood flow dynamics in neurogenic orthostatic hypotension: A systematic review and meta-analysis. Hypertension. 82:106−117. DOI:10.1161/HYPERTENSIONAHA.124.23188 View in Article CrossRef Google Scholar
[55]	Bidani A.K., Polichnowski A.J., Licea-Vargas H., et al. (2020). BP fluctuations and the real-time dynamics of renal blood flow responses in conscious rats. J. Am. Soc. Nephrol. 31:324−336. DOI:10.1681/ASN.2019070718 View in Article CrossRef Google Scholar
[56]	Minsinger K.D., Kassis H.M., Block C.A., et al. (2014). Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy. Am. J. Cardiol. 113:49−53. DOI:10.1016/j.amjcard.2013.08.040 View in Article CrossRef Google Scholar
[57]	Shakir M.A., Garratt K.N. and Wimmer N.J. (2024). Impact of ACIST CVi contrast delivery system on iodinated contrast media administration and waste. J. Invasive Cardiol. 36. DOI:10.25270/jic/24.00150. View in Article Google Scholar
[58]	Pfister M., Lue J.C.L., Stefanini F.R., et al. (2014). Comparison of reaction response time between hand and foot controlled devices in simulated microsurgical testing. Biomed. Res. Int. 2014:769296. DOI:10.1155/2014/769296 View in Article CrossRef Google Scholar
[59]	Endrikat J., Barbati R., Scarpa M., et al. (2018). Accuracy and repeatability of automated injector versus manual administration of an MRI contrast agent-results of a laboratory study. Invest. Radiol. 53:1−5. DOI:10.1097/RLI.0000000000000403 View in Article CrossRef Google Scholar
[60]	Pan H., Pan X., Cao Z., et al. (2026). Self-expanding sodium alginate sulfate drug-loaded microspheres for stabilized arterial embolization. Carbohydr. Polym. 380:125119. DOI:10.1016/j.carbpol.2026.125119 View in Article CrossRef Google Scholar
[61]	Lok C.E., Huber T.S., Orchanian-Cheff A., et al. (2024). Arteriovenous access for hemodialysis: A review. JAMA 331:1307−1317. DOI:10.1001/jama.2024.0535 View in Article CrossRef Google Scholar
[62]	Xu B., Tu S., Song L., et al. (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): A multicentre, randomised, sham-controlled trial. Lancet 398:2149−2159. DOI:10.1016/S0140-6736(21)02248-0 View in Article CrossRef Google Scholar
[63]	Boraschi P., Della Pina M.C. and Donati F. (2016). Graft complications following orthotopic liver transplantation: Role of non-invasive cross-sectional imaging techniques. Eur. J. Radiol. 85:1271−1283. DOI:10.1016/j.ejrad.2016.04.008 View in Article CrossRef Google Scholar
[64]	Chapman C.L., Benati J.M., Johnson B.D., et al. (2019). Renal and segmental artery hemodynamics during whole body passive heating and cooling recovery. J. Appl. Physiol. 127:974−983. DOI:10.1152/japplphysiol.00403.2019 View in Article CrossRef Google Scholar
[65]	Waki Y., Kamiya S., Li Y., et al. (2021). Preserving a replaced left hepatic artery arising from the left gastric artery during laparoscopic distal gastrectomy for gastric cancer. World J. Surg. 45:543−553. DOI:10.1007/s00268-020-05832-4 View in Article CrossRef Google Scholar
[66]	Lee J., Boas F.E., Duran-Struuck R., et al. (2024). Pigs as clinically relevant models for synergizing interventional oncology and immunotherapy. J. Vasc. Interv. Radiol. 35:809−817.e1. DOI:10.1016/j.jvir.2024.01.005 View in Article CrossRef Google Scholar
[67]	Nykonenko A., Vávra P., Zonča P. (2017). Anatomic peculiarities of pig and human liver. Exp. Clin. Transplant. 15:21−26. DOI:10.6002/ect.2016.0067 View in Article CrossRef Google Scholar
[68]	O’Brien C.C., Kolachalama V.B., Barber T.J., et al. (2013). Impact of flow pulsatility on arterial drug distribution in stent-based therapy. J. Control. Release. 168:115−124. DOI:10.1016/j.jconrel.2013.03.014 View in Article CrossRef Google Scholar
[69]	Xu D., Varshney A., Ma X., et al. (2020). Nonlinear hydrodynamic instability and turbulence in pulsatile flow. Proc. Natl. Acad. Sci. U.S.A. 117:11233−11249. DOI:10.1073/pnas.1913716117 View in Article CrossRef Google Scholar
[70]	Schmitt N., Floca R.O., Paech D., et al. (2021). Imaging artifacts of nonadhesive liquid embolic agents in conventional and cone-beam CT in a novel in vitro AVM model. Clin. Neuroradiol. 31:1141−1148. DOI:10.1007/s00062-021-01013-5 View in Article CrossRef Google Scholar
[71]	Schmitt N., Wucherpfennig L., Hohenstatt S., et al. (2023). Visibility of liquid embolic agents in fluoroscopy: A systematic in vitro study. J. Neurointerv. Surg. 15:594−599. DOI:10.1136/neurintsurg-2022-018958 View in Article CrossRef Google Scholar
[72]	Tao S., Han X., Shi D., et al. (2024). Portable device with nicking enzyme enhanced special RCA on μPADs toward sensitive detection of high-risk HPV infection. Anal. Chem. 96:12463−12472. DOI:10.1021/acs.analchem.4c02070 View in Article CrossRef Google Scholar
[73]	Kim K. and Lee W.G. (2023). Portable, automated and deep-learning-enabled microscopy for smartphone-tethered optical platform towards remote homecare diagnostics: A review. Small Methods. 7:e2200979. DOI:10.1002/smtd.202200979 View in Article CrossRef Google Scholar
[74]	Tong B., Xu J., Du J., et al. (2025). 2D (NH4)BiI3 enables non-volatile optoelectronic memories for machine learning. Nat. Commun. 16:1609. DOI:10.1038/s41467-025-56819-5 View in Article CrossRef Google Scholar

Cited by

ABOUT THIS ARTICLE

Cite this article:

Du T., Xiong Y., Yu Y., et al. (2026). Development and application of AI enabled automated drug delivery system for TACE guided by DSA. The Innovation Oncology 1:100009. https://doi.org/10.59717/j.xinn-oncol.2026.100009

Du T., Xiong Y., Yu Y., et al. (2026). Development and application of AI enabled automated drug delivery system for TACE guided by DSA. The Innovation Oncology 1:100009. https://doi.org/10.59717/j.xinn-oncol.2026.100009

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF

Figures(7) Tables(1)

Supplementary Information

download_supplementary
SI-Extended-TIO-DOI-9

Article Metrics

Article views(1457) PDF downloads(449)

Development and application of AI enabled automated drug delivery system for TACE guided by DSA

GRAPHICAL ABSTRACT

PUBLIC SUMMARY

ABSTRACT